BIOMAT Database Logo BIOMAT Database Logo

Human AML cells in NOD/SCID mice: engraftment potential and gene expression. 2002

R Lumkul, and N-C Gorin, and M T Malehorn, and G T Hoehn, and R Zheng, and B Baldwin, and D Small, and S Gore, and D Smith, and P S Meltzer, and C I Civin
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.

Most cases of human acute myeloid leukemia (AML) engraft in irradiated non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice. Intravenous transfer of as few as 10(5) human AML cells resulted in engraftment. Cases with poor prognosis clinical features, including FLT3 mutations, tended to engraft efficiently. Nevertheless, AML cells obtained from patients at relapse did not engraft more efficiently than cells obtained from the same patients at initial diagnosis. One passage of human AML cells in NOD/SCID mice did not appear to select for increased virulence, as measured by serial transplantation efficiency. Finally, cDNA microarray analyses indicated that approximately 95% of genes were expressed at similar levels in human AML cells immunopurified after growth in mice, as compared to cells assessed directly from patients. Thus, the growth of human AML cells in NOD/SCID mice could yield large numbers of human AML cells for direct experimental use and could also function as a renewable, potentially unlimited source of leukemia cells, via serial transplantation.

UI MeSH Term Description Entries
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

R Lumkul, and N-C Gorin, and M T Malehorn, and G T Hoehn, and R Zheng, and B Baldwin, and D Small, and S Gore, and D Smith, and P S Meltzer, and C I Civin
Human interleukin-15 improves engraftment of human T cells in NOD-SCID mice.
February 2006, Clinical and vaccine immunology : CVI,
R Lumkul, and N-C Gorin, and M T Malehorn, and G T Hoehn, and R Zheng, and B Baldwin, and D Small, and S Gore, and D Smith, and P S Meltzer, and C I Civin
Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice.
April 1995, The American journal of pathology,
R Lumkul, and N-C Gorin, and M T Malehorn, and G T Hoehn, and R Zheng, and B Baldwin, and D Small, and S Gore, and D Smith, and P S Meltzer, and C I Civin
Selective expansion and engraftment of human CD16+ NK cells in NOD/SCID mice.
December 2005, European journal of immunology,
R Lumkul, and N-C Gorin, and M T Malehorn, and G T Hoehn, and R Zheng, and B Baldwin, and D Small, and S Gore, and D Smith, and P S Meltzer, and C I Civin
Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
November 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
R Lumkul, and N-C Gorin, and M T Malehorn, and G T Hoehn, and R Zheng, and B Baldwin, and D Small, and S Gore, and D Smith, and P S Meltzer, and C I Civin
Engraftment potential of human fetal hematopoietic cells in NOD/SCID mice is not restricted to mitotically quiescent cells.
July 2002, Blood,
R Lumkul, and N-C Gorin, and M T Malehorn, and G T Hoehn, and R Zheng, and B Baldwin, and D Small, and S Gore, and D Smith, and P S Meltzer, and C I Civin
Engraftment and development of human CD34(+)-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice.
July 1997, Blood,
R Lumkul, and N-C Gorin, and M T Malehorn, and G T Hoehn, and R Zheng, and B Baldwin, and D Small, and S Gore, and D Smith, and P S Meltzer, and C I Civin
Ex vivo expansion and engraftment potential of cord blood-derived CD34+ cells in NOD/SCID mice.
June 2001, Annals of the New York Academy of Sciences,
R Lumkul, and N-C Gorin, and M T Malehorn, and G T Hoehn, and R Zheng, and B Baldwin, and D Small, and S Gore, and D Smith, and P S Meltzer, and C I Civin
Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.
April 2003, Leukemia,
R Lumkul, and N-C Gorin, and M T Malehorn, and G T Hoehn, and R Zheng, and B Baldwin, and D Small, and S Gore, and D Smith, and P S Meltzer, and C I Civin
Intra-thymic/splenic engraftment of human T cells in HLA-DR1 transgenic NOD/scid mice.
January 2004, Cellular immunology,
R Lumkul, and N-C Gorin, and M T Malehorn, and G T Hoehn, and R Zheng, and B Baldwin, and D Small, and S Gore, and D Smith, and P S Meltzer, and C I Civin
A strategy for enhancing the engraftment of human hematopoietic stem cells in NOD/SCID mice.
December 2013, Annals of hematology,
Copied contents to your clipboard!